American Oriental Bioengineering, Inc.
AOBI · OTC
9/30/2013 | 6/30/2013 | 3/31/2013 | 12/31/2012 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -11.3% | -3.7% | -66.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 17.3% | 24.7% | 21.4% | 43.3% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -89.3% | -35.8% | -80.8% | -50% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -118.1% | -63.5% | -100.5% | -57.5% |
| EPS Diluted | -290.36 | -176.28 | -288.69 | -485.66 |
| % Growth | -64.7% | 38.9% | 40.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |